Ion Cotarla
Impact in
- Oncology top 5%
- Cancer Risks and Factors
- Cytokine Signaling Pathways and Interactions
- Global Cancer Incidence and Screening
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 7
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 1
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Ramona Dumitrescu (1 shared paper)Brian Seal (3 shared papers)Alyssa Klein (1 shared paper)Apar Kishor Ganti (1 shared paper)Engels Chou (1 shared paper)Priscilla A. Furth (3 shared papers)Shuxun Ren (2 shared papers)Ying Zhang (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer (1 paper)Journal of Thoracic Oncology (1 paper)JCO Oncology Practice (1 paper)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Ion Cotarla
17 papers receiving 1.1k citations
Ion Cotarla's Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 563
- Cancer Research 183
- Pulmonary and Respiratory Medicine 347
- Genetics 173
- Molecular Biology 384
Countries citing papers authored by Ion Cotarla
This map shows the geographic impact of Ion Cotarla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ion Cotarla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ion Cotarla more than expected).
Fields of papers citing papers by Ion Cotarla
This network shows the impact of papers produced by Ion Cotarla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ion Cotarla. The network helps show where Ion Cotarla may publish in the future.
Co-authors
The 25 scholars most cited alongside Ion Cotarla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US Hit paper breakdown → | 2021 | 387 |
| 2 | 2005 | 351 | |
| 3 | 2003 | 117 | |
| 4 | 2012 | 62 | |
| 5 | 2012 | 60 | |
| 6 | 2002 | 26 | |
| 7 | 2009 | 17 | |
| 8 | 2008 | 15 | |
| 9 | 2012 | 14 | |
| 10 | 2020 | 13 | |
| 11 | 2007 | 8 | |
| 12 | Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment | 2022 | 7 |
| 13 | 2023 | 6 | |
| 14 | 2010 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2023 | 0 | |
| 19 | 2022 | 0 |
About Ion Cotarla
Ion Cotarla is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Economics and Econometrics, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Economic and Financial Impacts of Cancer (4 papers), Lung Cancer Research Studies (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Cancer Treatment and Pharmacology (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Oncology (563 citations), Cancer Research (183 citations), Pulmonary and Respiratory Medicine (347 citations), Genetics (173 citations) and Molecular Biology (384 citations). Ion Cotarla has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Ramona Dumitrescu, Brian Seal, Alyssa Klein, Apar Kishor Ganti, Engels Chou, Priscilla A. Furth, Shuxun Ren, Ying Zhang, Edmund A. Gehan and Baljit Singh. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer, Journal of Thoracic Oncology and JCO Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.